TAK:NYSE
Takeda Pharmaceutical Company
18,68 USD
arrow_downward
−0,27%(−0,050) 1D
18,86 USD
arrow_upward
+0,96% (+0,18)todayPrije radnog vremena
Zatvoreno: 12. lis, 16:00:05 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za TAK...
Otvori
18,79 USD
Najviša
18,79 USD
Najniža
18,66 USD
Trž. kap.
59,14 mlr.
Prosj. kol.
2,38 mil.
Količina
5,48 tis.
Dividenda
3,37 %
Kvartalna dividenda
0,16 USD
Datum nakon isplate dividende
29. ruj 2026.
52-tjed. najviša
19,10 USD
52-tjed. najniža
12,99 USD
EPS
−0,33 USD
Beta
−0,06
Dionice u optjecaju
3,20 mlr.
Broj djelatnika
47 tis.
Otvori
18,79 USD
Najviša
18,79 USD
Najniža
18,66 USD
Trž. kap.
59,14 mlr.
Prosj. kol.
2,38 mil.
Količina
5,48 tis.
Dividenda
3,37 %
Kvartalna dividenda
0,16 USD
Datum nakon isplate dividende
29. ruj 2026.
52-tjed. najviša
19,10 USD
52-tjed. najniža
12,99 USD
EPS
−0,33 USD
Beta
−0,06
Dionice u optjecaju
3,20 mlr.
Broj djelatnika
47 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 48 minuta
Analysts raised target for Takeda Pharmaceutical stock to JPY 5,800
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Company – informacije
Glavni izvršni direktorChristophe Weber | Christophe Weber
Zaposlenici47 tis.
Osnovano12. lip 1781.
Sjedište-
Sektor-
Web-lokacijatakeda.com